Revaia

Revaia is a Paris-headquartered growth-equity venture capital firm and claims the distinction of being Europe's largest venture fund under female leadership. Founded by Alice Albizzati and Elina Berrebi, it backs B2B software companies at Series B and C stage across Europe, with particular interest in healthcare technology, workforce software, and SaaS businesses that are growing into mid-market and enterprise segments. The fund operates across France, Germany, and the UK, with a strong emphasis on companies that have reached sustainable unit economics.

Revaia led the £30m Series C for Semble, a UK-based health-tech company, in a round that also included Octopus Ventures as a co-investor. The investment reflects Revaia's continued focus on UK healthcare software at a time when GP technology and clinical workflow tools are attracting dedicated European growth capital. Semble's round was among several UK health-tech raises in the period alongside IMU Biosciences and Laverock Therapeutics.

Revaia's positioning as Europe's largest woman-led VC has made it a reference point in discussions about institutional diversity in venture. It manages over €500m under management across its funds and regularly co-invests with other European growth-equity specialists, bringing operational support rather than purely financial capital to its portfolio companies.